Therapeutic effects of colchicine in the management of Peyronie's disease: A randomized double-blind, placebo-controlled study

International Journal of Impotence Research

Volumn 16, Issue 3, 2004, Pages 238-243

  Safarinejad, M R ^a  

^a University of Medical Science   (Iran)

Author keywords

Colchicine; Drug treatment; Peyronie's disease

Indexed keywords

ALPHA TOCOPHEROL; AMINOBENZOIC ACID; COLCHICINE; PLACEBO; TAMOXIFEN;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PENIS ERECTION; PEYRONIE DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; X RAY ANALYSIS;

ADULT; COLCHICINE; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; PAIN; PENILE INDURATION; PENIS; PLACEBOS; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 3042698497     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901185     Document Type: Article

References (31)

1. Levine LA. Treatment of Peyronie's disease with intralesional verapamil injection. J Urol 1997; 158: 1395-1401.
2. Carson CC. Potassium para-aminobenzoate for the treatment of Peyronie's disease: is it effective? Tech Urol 1997; 3: 135-140.
3. Gelbard MK, Dorey F, James K. The natural history of Peyronie's disease. J Urol 1990; 144: 1376-1381.
4. Ralph DJ, Brooks MD, Bottazzo GF, Pyror JP. The treatment of Peyronie's disease with tamoxifen. Br J Urol 1992; 70: 648-653.
5. Morgan RJ, Pryor JP. Procarbazine (Natulan) in the treatment of Peyronie's disease. Br J Urol 1978; 50: 111-116.
6. Akkus E et al. Is colchicine effective in Peyronie's disease? A pilot study. Urology 1994; 44: 291-296.
7. Winter CC, Khanna R. Peyronie's disease: results with dermojet injection of dexamethasone. J Urol 1975; 114: 898-903.
8. Gelbard MK, James K, Riach P, Dorey F. Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study. J Urol 1993; 149: 56-60.
9. Morales A, Bruce AW. The treatment of Peyronie's disease with parathyroid hormone. J Urol 1975; 114: 901-906.
10. Bartsch G, Menander-Huber KB, Marberger H. Orgotein, a new drug for the treatment of Peyronie's disease. Eur J Rheumatol Inflamm 1981; 4: 250-255.
11. Duncan MR, Berman B, Nseyo UO. Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblast by interferons-alpha, -beta and -gamma. Scand J Urol Nephrol 1991; 25: 89-94.
12. Incrocci L, Hop W, Slob A. Current sexual functioning in 106 patients with Peyronie's disease treated with radiotherapy 9 years earlier. Urology 2000; 56: 1030-1033.
13. Hauck E et al. Extracorporeal shock wave therapy in the treatment of Peyronie's disease. Eur Urol 2000; 38: 663-670.
14. Frank IN, Scott WW. The ultrasonic treatment of Peyronie's disease. J Urol 1971; 106: 83-88.
15. El-Sakka AI et al. The effect of surgical trauma on rat tunica albuginea. J Urol 1998; 159: 1700-1706.
16. Diegelmann RF, Peterkofsky B. Inhibition of collagen secretion from bone and cultured fibroblast by microtubular disruptive drugs. Proc Natl Acad Sci USA 1972; 69: 892-898.
17. Rosen RC et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of Erectile dysfunction. Urology 1997; 49: 620-625.
18. Kelami A. Classification of congenital and acquired penile deviation. Urol Int 1983; 38: 822-826.
19. Steward S, Malto M, Sandberg L, Colburn KK. Increase serum level of anti-elastin antibodies in patients with Peyronie's disease. J Urol 1994; 152: 105-111.
20. Somers KD et al. Isolation and characterization of collagen in Peyronie's disease. J Urol 1989; 141: 629-634.
21. Border WA, Ruoslahti E. Transforming growth factor beta in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1-7.
22. Taylor AC. The mechanism of colchicine inhibition of mitosis. I. Kinetics of inhibition and the binding of H3-colchicine. J Cell Biol 1965; 25: 145-150.
23. Tilney LG, Hiramoto Y, Marsland D. Studies on the microtubules in heliozoa. J Cell Biol 1966; 29: 77-82.
24. Ehrilich HP, Bornstein P. Microtubules in transcellular movement of procollagen. Nature (New Biol) 1972; 238: 257-261.
25. El-Sakka AI et al. The effects of colchicine on a Peyronie's-like condition in an animal model. J Urol 1999; 161: 1980-1983.
26. Kadioglu A et al. Treatment of Peyronie's disease with oral colchicine: long term results and predictive parameters of successful outcome. Int J Impot Res 2000; 12: 169-175.
27. Claudio T et al. Tamoxifen versus placebo in the treatment of Peyronie's disease. J Urol 1999; 162: 2003-2008.
28. Levine LA, Goldman KE, Greenfield JM. Experience with intraplaque injection of verapamil for Peyronie's disease. J Urol 2002; 168: 621-626.
29. Husain J et al. Extracorporeal shockwave therapy in the management of Peyronie's disease. Br J Urol 2000; 68: 466-468.
30. Williams J, Thomas GG. The natural history of Peyronie's disease. J Urol 1970; 73: 75-79.
31. Kadioglu A. Lessons learned from 307 men with Peyronie's disease. J Urol Suppl 2001; 165: 202, abstract 838.